Skip to Content

Elestrin Approval History

FDA Approved: Yes (First approved December 15, 2006)
Brand name: Elestrin
Generic name: estradiol
Dosage form: Gel
Previous Name: Bio-E-Gel
Company: BioSante Pharmaceuticals, Inc.
Treatment for: Postmenopausal Symptoms

Elestrin is a fast-drying transdermal gel formulation of bio-identical estradiol indicated for the treatment of moderate-to-severe vasomotor symptoms (hot flashes) associated with menopause.

Development History and FDA Approval Process for Elestrin

DateArticle
Dec 18, 2006Approval Elestrin BioSante Pharmaceuticals, Inc. - Treatment for Menopausal Vasomotor Symptoms
Apr 19, 2006BioSante Pharmaceuticals Announces FDA Filing and Review of NDA for Bio-E-Gel
Feb 16, 2006BioSante Pharmaceuticals Announces Bio-E-Gel NDA Submission

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide